Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 21 12:04PM ET
15.31
Dollar change
-0.15
Percentage change
-0.97
%
Index- P/E- EPS (ttm)-4.53 Insider Own47.17% Shs Outstand2.08M Perf Week-2.12%
Market Cap48.83M Forward P/E- EPS next Y- Insider Trans0.33% Shs Float1.38M Perf Month-4.01%
Income-18.31M PEG- EPS next Q- Inst Own12.84% Short Float2.09% Perf Quarter-8.19%
Sales1.00M P/S48.83 EPS this Y- Inst Trans9.04% Short Ratio1.00 Perf Half Y-47.23%
Book/sh5.75 P/B2.66 EPS next Y- ROA-63.03% Short Interest0.03M Perf Year3.11%
Cash/sh13.03 P/C1.17 EPS next 5Y- ROE-2570.57% 52W Range7.38 - 30.99 Perf YTD33.13%
Dividend Est.- P/FCF- EPS past 5Y18.96% ROI-121.72% 52W High-50.60% Beta0.65
Dividend TTM- Quick Ratio6.69 Sales past 5Y-26.58% Gross Margin91.00% 52W Low107.45% ATR (14)1.02
Dividend Ex-Date- Current Ratio6.69 EPS Y/Y TTM57.13% Oper. Margin-2399.50% RSI (14)53.01 Volatility8.91% 7.46%
Employees16 Debt/Eq0.01 Sales Y/Y TTM11011.11% Profit Margin-1830.60% Recom1.00 Target Price160.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q73.16% Payout- Rel Volume0.27 Prev Close15.46
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 12 AMC Avg Volume28.82K Price15.31
SMA204.24% SMA506.81% SMA200-15.63% Trades Volume3,478 Change-0.97%
Date Action Analyst Rating Change Price Target Change
May-30-19Initiated H.C. Wainwright Buy
Apr-10-18Downgrade Stifel Buy → Hold $12 → $1
Mar-08-18Initiated ROTH Capital Buy $17
Feb-08-18Initiated Northland Capital Outperform $28
Sep-26-16Initiated H.C. Wainwright Buy $13
Sep-04-15Initiated Canaccord Genuity Buy $15
Aug-24-15Initiated Stifel Buy $17
Aug-24-15Initiated Piper Jaffray Overweight $24
Nov-12-24 05:04PM
04:05PM
Oct-26-24 05:01PM
Aug-08-24 05:26PM
04:15PM
11:23AM Loading…
Jul-29-24 11:23AM
06:53AM
Jul-26-24 04:05PM
Jun-24-24 04:05PM
May-28-24 08:00AM
May-20-24 12:00PM
May-09-24 10:57PM
05:02PM
04:51PM
Mar-19-24 08:30AM
08:24AM Loading…
Mar-13-24 08:24AM
08:00AM
Mar-04-24 03:49PM
08:00AM
Mar-01-24 08:00AM
Feb-28-24 08:00AM
Feb-22-24 04:00PM
Nov-09-23 05:06PM
04:30PM
Nov-08-23 08:00AM
Nov-02-23 08:00AM
Nov-01-23 08:00AM
Sep-27-23 08:30AM
Sep-26-23 08:30AM
Sep-22-23 05:22AM
08:30AM Loading…
Sep-18-23 08:30AM
Aug-24-23 12:35PM
Aug-16-23 02:44PM
Aug-11-23 04:37PM
04:30PM
Aug-10-23 08:33AM
Jun-16-23 08:00AM
Jun-15-23 07:33AM
May-24-23 09:00AM
May-12-23 08:11AM
May-11-23 04:33PM
04:15PM
Apr-20-23 08:00AM
Mar-30-23 08:31AM
Mar-17-23 01:01PM
Mar-06-23 06:11PM
05:56PM
08:02AM
Mar-03-23 05:06AM
Feb-27-23 08:02AM
Feb-01-23 05:00PM
Jan-20-23 09:03AM
Jan-09-23 08:00AM
Dec-22-22 06:00AM
Dec-13-22 08:15AM
Dec-03-22 07:04AM
Nov-15-22 02:46PM
Nov-10-22 06:45PM
05:25PM
Nov-02-22 07:26AM
Sep-23-22 07:04AM
Aug-19-22 12:42PM
Aug-18-22 06:41AM
Aug-15-22 06:43PM
Aug-13-22 08:25AM
Aug-09-22 06:09AM
Jul-27-22 03:01PM
07:00AM
Jul-25-22 08:22AM
07:00AM
Jun-04-22 11:00AM
Jun-01-22 06:54AM
May-19-22 06:40AM
May-12-22 07:45AM
Mar-31-22 07:34PM
Mar-29-22 09:47PM
Mar-03-22 08:48PM
Jan-13-22 08:30AM
Jan-12-22 05:38PM
Dec-06-21 06:43PM
05:19PM
Dec-03-21 10:00AM
Nov-22-21 06:06AM
Nov-09-21 09:45AM
08:30AM
Oct-28-21 03:06PM
01:38PM
Oct-20-21 09:00AM
Oct-12-21 07:30AM
Sep-23-21 04:30PM
Sep-13-21 03:40PM
Aug-17-21 10:00AM
Aug-04-21 07:15PM
04:30PM
Jul-27-21 07:50AM
Jun-29-21 07:30AM
Jun-22-21 09:48PM
10:11AM
08:28AM
07:30AM
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEKHRI PAUL JPres, CEO and Exec ChairpersonNov 15 '24Buy16.653,15652,5433,156Nov 19 04:31 PM
SEKHRI PAUL JPres, CEO and Exec ChairpersonNov 18 '24Buy16.961,84431,2695,000Nov 19 04:31 PM
Last Close
Nov 21 12:13PM ET
214.42
Dollar change
+3.79
Percentage change
1.80
%
VEEV Veeva Systems Inc daily Stock Chart
Index- P/E57.23 EPS (ttm)3.75 Insider Own8.93% Shs Outstand161.26M Perf Week-6.66%
Market Cap34.72B Forward P/E31.37 EPS next Y6.83 Insider Trans-0.13% Shs Float147.47M Perf Month-1.52%
Income615.26M PEG3.01 EPS next Q1.58 Inst Own79.66% Short Float1.63% Perf Quarter7.61%
Sales2.57B P/S13.49 EPS this Y28.89% Inst Trans0.81% Short Ratio2.55 Perf Half Y4.81%
Book/sh32.04 P/B6.69 EPS next Y9.56% ROA10.65% Short Interest2.40M Perf Year21.55%
Cash/sh30.17 P/C7.11 EPS next 5Y19.00% ROE13.18% 52W Range165.12 - 240.68 Perf YTD11.38%
Dividend Est.- P/FCF35.74 EPS past 5Y16.91% ROI11.77% 52W High-10.91% Beta0.81
Dividend TTM- Quick Ratio5.01 Sales past 5Y22.64% Gross Margin73.21% 52W Low29.86% ATR (14)6.06
Dividend Ex-Date- Current Ratio5.01 EPS Y/Y TTM11.50% Oper. Margin22.75% RSI (14)46.60 Volatility3.21% 2.59%
Employees7172 Debt/Eq0.01 Sales Y/Y TTM15.29% Profit Margin23.91% Recom2.00 Target Price248.92
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q52.05% Payout0.00% Rel Volume0.80 Prev Close210.63
Sales Surprise1.25% EPS Surprise5.59% Sales Q/Q14.56% EarningsDec 05 AMC Avg Volume942.54K Price214.42
SMA20-1.93% SMA50-0.07% SMA2004.03% Trades Volume338,656 Change1.80%
Date Action Analyst Rating Change Price Target Change
Nov-19-24Initiated Scotiabank Sector Perform $235
Oct-08-24Initiated Exane BNP Paribas Outperform $286
Aug-27-24Reiterated Citigroup Buy $256 → $273
Jul-09-24Initiated BTIG Research Buy $240
Oct-25-23Upgrade Wells Fargo Equal Weight → Overweight $211 → $229
Oct-13-23Initiated Jefferies Buy $265
Jun-28-23Downgrade Morgan Stanley Equal-Weight → Underweight $181
Jun-01-23Upgrade Guggenheim Neutral → Buy $226
Mar-17-23Downgrade Truist Buy → Hold $205 → $195
Feb-23-23Downgrade Guggenheim Buy → Neutral
Today 07:03AM
04:30AM
Nov-20-24 04:00AM
Nov-19-24 07:03AM
Nov-18-24 05:45PM
08:00PM Loading…
Nov-17-24 08:00PM
Nov-14-24 04:14PM
10:03AM
09:00AM
07:03AM
Nov-12-24 09:30AM
Nov-11-24 05:45PM
04:03AM
Nov-08-24 08:37AM
Nov-04-24 06:30AM
05:45PM Loading…
Nov-01-24 05:45PM
Oct-31-24 09:00AM
Oct-29-24 07:03AM
Oct-25-24 05:45PM
Oct-24-24 08:00AM
Oct-23-24 05:50PM
Oct-21-24 09:30AM
Oct-20-24 03:42PM
Oct-17-24 05:50PM
09:00AM
04:41AM
Oct-15-24 04:30PM
Oct-14-24 04:59AM
Oct-13-24 10:28AM
Oct-11-24 12:32PM
05:50PM Loading…
Oct-10-24 05:50PM
Oct-03-24 09:00AM
06:45AM
Oct-02-24 07:03AM
Sep-27-24 11:30AM
Sep-24-24 07:03AM
Sep-23-24 09:50AM
09:35AM
Sep-18-24 09:00AM
Sep-14-24 02:51PM
Sep-11-24 08:46AM
07:00AM
Sep-09-24 05:04PM
Sep-08-24 08:00PM
Sep-06-24 04:08AM
Sep-05-24 09:50AM
09:15AM
09:00AM
07:45AM
07:03AM
Sep-04-24 09:00PM
Sep-03-24 09:00PM
Aug-30-24 01:45PM
Aug-29-24 01:33PM
12:51PM
08:31AM
Aug-28-24 11:45PM
06:00PM
05:20PM
04:29PM
04:18PM
04:05PM
Aug-27-24 07:03AM
03:02AM
Aug-23-24 09:15AM
Aug-22-24 09:00AM
07:03AM
Aug-21-24 09:30AM
Aug-20-24 09:00PM
Aug-19-24 05:45PM
07:31AM
Aug-14-24 09:53AM
Aug-13-24 07:03AM
Aug-12-24 05:55PM
Aug-07-24 04:15PM
Aug-05-24 05:45PM
Aug-01-24 09:00AM
Jul-30-24 05:45PM
Jul-25-24 09:03AM
07:03AM
Jul-24-24 05:45PM
12:02PM
Jul-23-24 09:30AM
Jul-18-24 05:50PM
09:50AM
08:28AM
Jul-16-24 09:45AM
Jul-15-24 10:20AM
Jul-14-24 07:00AM
Jul-12-24 05:50PM
Jul-09-24 07:59AM
Jul-03-24 10:45AM
10:23AM
Jun-28-24 09:45AM
Jun-26-24 09:45AM
Jun-25-24 10:25AM
Jun-24-24 07:09AM
Jun-20-24 12:07PM
06:32AM
06:24AM
Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schwenger Thomas D.Pres. & Chief Customer OfficerNov 08 '24Sale240.011,126270,25227,013Nov 12 10:48 AM
Schwenger Thomas D.DirectorNov 08 '24Proposed Sale240.011,126270,252Nov 08 12:28 PM
Zuppas Eleni NitsaPresident & Chief of StaffOct 01 '24Option Exercise0.001,324022,645Oct 02 05:58 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerOct 01 '24Option Exercise0.001,909028,974Oct 02 05:55 PM
DIAMOND KRISTINEChief Accounting OfficerOct 01 '24Option Exercise0.002040692Oct 02 05:54 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryOct 01 '24Option Exercise0.001,120010,155Oct 02 05:53 PM
Cabral Timothy SInterim CFOSep 01 '24Option Exercise0.0031501,426Sep 03 05:56 PM
Carges Mark TDirectorSep 01 '24Option Exercise0.003570357Sep 03 05:00 PM
Hedley Mary LynneDirectorSep 01 '24Option Exercise0.0034305,075Sep 03 04:57 PM
Hung PriscillaDirectorSep 01 '24Option Exercise0.0034303,281Sep 03 04:56 PM
Hunt NimrataDirectorSep 01 '24Option Exercise0.0034303,174Sep 03 04:55 PM
MOHR MARSHALLDirectorSep 01 '24Option Exercise0.0038503,667Sep 03 04:53 PM
Ritter GordonDirectorSep 01 '24Option Exercise0.0039901,102Sep 03 04:52 PM
SEKHRI PAUL JDirectorSep 01 '24Option Exercise0.00329015,683Sep 03 04:51 PM
Wallach Matthew JDirectorSep 01 '24Option Exercise0.003290104,934Sep 03 04:49 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryAug 21 '24Sale200.002,353470,6009,035Aug 21 05:10 PM
Faddis JonathanOfficerAug 21 '24Proposed Sale200.002,353470,600Aug 21 04:27 PM
Epstein StaceyChief Marketing OfficerJul 01 '24Option Exercise0.008910891Jul 02 05:21 PM
Zuppas Eleni NitsaPresident & Chief of StaffJul 01 '24Option Exercise0.001,324021,321Jul 02 05:21 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerJul 01 '24Option Exercise0.001,909027,867Jul 02 05:21 PM
DIAMOND KRISTINEChief Accounting OfficerJul 01 '24Option Exercise0.002040561Jul 02 05:21 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryJul 01 '24Option Exercise0.001,120011,788Jul 02 05:21 PM
Cabral Timothy SInterim CFOJun 07 '24Sale184.3315,0002,764,9318,391Jun 07 05:53 PM
Hung PriscillaDirectorJun 01 '24Option Exercise0.0030202,938Jun 03 05:12 PM
Cabral Timothy SDirectorJun 01 '24Option Exercise0.0027801,111Jun 03 05:11 PM
Carges Mark TDirectorJun 01 '24Option Exercise0.003150315Jun 03 05:10 PM
Hedley Mary LynneDirectorJun 01 '24Option Exercise0.0030204,732Jun 03 05:09 PM
Hunt NimrataDirectorJun 01 '24Option Exercise0.0030202,831Jun 03 05:09 PM
MOHR MARSHALLDirectorJun 01 '24Option Exercise0.0033903,282Jun 03 05:08 PM
Ritter GordonDirectorJun 01 '24Option Exercise0.003520703Jun 03 05:08 PM
SEKHRI PAUL JDirectorJun 01 '24Option Exercise0.00290015,354Jun 03 05:07 PM
Wallach Matthew JDirectorJun 01 '24Option Exercise0.002900104,605Jun 03 05:06 PM
MATEO ALANEVP Global SalesApr 23 '24Sale200.863,391681,11621,983Apr 23 07:09 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryApr 15 '24Sale207.423,598746,29710,668Apr 16 04:33 PM
Schwenger Thomas D.President and COOApr 01 '24Option Exercise0.002,268026,610Apr 02 03:51 PM
Zuppas Eleni NitsaChief Marketing OfficerApr 01 '24Option Exercise0.001,620020,677Apr 02 03:49 PM
MATEO ALANEVP Global SalesApr 01 '24Option Exercise0.006,944026,983Apr 02 03:47 PM
DIAMOND KRISTINEChief Accounting OfficerApr 01 '24Option Exercise0.002200435Apr 02 03:44 PM
Bowman Brent RFormer Chief Financial OfficerApr 01 '24Option Exercise0.001,29609,287Apr 02 03:43 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryApr 01 '24Option Exercise0.001,296019,729Apr 02 03:41 PM
Cabral Timothy SDirectorMar 07 '24Sale226.0415,0003,390,65723,391Mar 07 05:35 PM
Cabral Timothy SDirectorMar 01 '24Option Exercise0.002770833Mar 05 02:29 PM
Hung PriscillaDirectorMar 01 '24Option Exercise0.0030202,636Mar 05 02:27 PM
Hunt NimrataDirectorMar 01 '24Option Exercise0.0030202,529Mar 05 02:27 PM
MOHR MARSHALLDirectorMar 01 '24Option Exercise0.0033902,943Mar 05 02:26 PM
Ritter GordonDirectorMar 01 '24Option Exercise0.003510351Mar 05 02:25 PM
SEKHRI PAUL JDirectorMar 01 '24Option Exercise0.00290015,064Mar 05 02:24 PM
Wallach Matthew JDirectorMar 01 '24Option Exercise0.002900104,315Mar 05 02:24 PM
Carges Mark TDirectorMar 01 '24Option Exercise0.003140314Mar 05 02:23 PM
Hedley Mary LynneDirectorMar 01 '24Option Exercise0.0030204,430Mar 05 02:22 PM
Wallach Matthew JDirectorFeb 05 '24Sale203.435,0001,017,147104,025Feb 06 08:02 PM
Schwenger Thomas D.President and COOJan 22 '24Sale210.021,238260,00124,342Jan 24 01:59 PM
MATEO ALANEVP Global SalesJan 17 '24Sale204.72910186,29521,983Jan 18 11:48 AM
Zuppas Eleni NitsaChief Marketing OfficerJan 12 '24Option Exercise135.493,000406,47022,057Jan 12 07:37 PM
Zuppas Eleni NitsaChief Marketing OfficerJan 12 '24Sale204.753,000614,25019,057Jan 12 07:37 PM
Zuppas Eleni NitsaChief Marketing OfficerJan 09 '24Option Exercise135.494,350589,38223,407Jan 11 07:10 PM
Zuppas Eleni NitsaChief Marketing OfficerJan 09 '24Sale192.614,350837,86019,057Jan 11 07:10 PM
Wallach Matthew JDirectorJan 05 '24Sale186.055,000930,238109,025Jan 08 01:16 PM
DIAMOND KRISTINEChief Accounting OfficerJan 01 '24Option Exercise0.003650365Jan 03 01:23 PM
Zuppas Eleni NitsaChief Marketing OfficerJan 01 '24Option Exercise0.001,619019,680Jan 03 01:23 PM
Schwenger Thomas D.President and COOJan 01 '24Option Exercise0.002,267026,277Jan 03 01:22 PM
MATEO ALANEVP Global SalesJan 01 '24Option Exercise0.001,943023,926Jan 03 01:21 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryJan 01 '24Option Exercise0.001,295018,941Jan 03 01:21 PM
Bowman Brent RChief Financial OfficerJan 01 '24Option Exercise0.001,29508,499Jan 03 01:20 PM
Hedley Mary LynneDirectorDec 28 '23Sale191.07428,0254,128Dec 28 05:24 PM
Hedley Mary LynneDirectorDec 27 '23Sale190.96417,8294,170Dec 28 05:24 PM
MATEO ALANEVP Global SalesDec 22 '23Option Exercise26.996,280169,49728,263Dec 22 07:58 PM
MATEO ALANEVP Global SalesDec 22 '23Sale190.006,2801,193,20021,983Dec 22 07:58 PM
Cabral Timothy SDirectorDec 14 '23Sale181.445,000907,18938,391Dec 14 03:09 PM
Cabral Timothy SDirectorDec 07 '23Sale168.7410,0001,687,35843,391Dec 08 01:13 PM
Wallach Matthew JDirectorDec 04 '23Sale179.155,000895,731114,025Dec 05 12:37 PM
Cabral Timothy SDirectorDec 01 '23Option Exercise0.002780556Dec 04 12:52 PM
Carges Mark TDirectorDec 01 '23Option Exercise0.003150315Dec 01 07:04 PM
Hedley Mary LynneDirectorDec 01 '23Option Exercise0.0030304,211Dec 01 07:01 PM
Hung PriscillaDirectorDec 01 '23Option Exercise0.0030302,334Dec 01 07:00 PM
Hunt NimrataDirectorDec 01 '23Option Exercise0.0030302,227Dec 01 06:53 PM
MOHR MARSHALLDirectorDec 01 '23Option Exercise0.0034002,604Dec 01 06:50 PM
Ritter GordonDirectorDec 01 '23Option Exercise0.0035201,001,463Dec 01 06:47 PM
SEKHRI PAUL JDirectorDec 01 '23Option Exercise0.00290014,774Dec 01 06:41 PM
Wallach Matthew JDirectorDec 01 '23Option Exercise0.002900119,025Dec 01 06:38 PM
MATEO ALANEVP Global SalesNov 28 '23Option Exercise135.492,214299,97521,983Nov 29 01:36 PM